SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Recruiting · NCT06804161 · Registry updated 2025-12-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension | Atrial Hypertension | Recruiting | Phase 3 | 2025-12-22 | NCT06804161 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Prof. Dr. med. Ingo Eitel | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Universität zu Lübeck | Lübeck | Germany | 5 |